Jushi (OTCMKTS:JUSHF – Get Free Report) is one of 53 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its peers? We will compare Jushi to similar companies based on the strength of its profitability, analyst recommendations, valuation, institutional ownership, earnings, risk and dividends.
Volatility & Risk
Jushi has a beta of -0.16, meaning that its stock price is 116% less volatile than the S&P 500. Comparatively, Jushi’s peers have a beta of 1.40, meaning that their average stock price is 40% more volatile than the S&P 500.
Institutional and Insider Ownership
21.7% of Jushi shares are held by institutional investors. Comparatively, 14.3% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 21.0% of Jushi shares are held by insiders. Comparatively, 21.5% of shares of all “Medicinals & botanicals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Valuation & Earnings
Gross Revenue | Net Income | Price/Earnings Ratio | |
Jushi | $269.45 million | -$65.10 million | -1.93 |
Jushi Competitors | $323.20 million | -$162.62 million | -10.00 |
Jushi’s peers have higher revenue, but lower earnings than Jushi. Jushi is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Analyst Ratings
This is a breakdown of recent ratings for Jushi and its peers, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Jushi | 0 | 2 | 0 | 0 | 2.00 |
Jushi Competitors | 203 | 531 | 843 | 66 | 2.47 |
As a group, “Medicinals & botanicals” companies have a potential upside of 70.25%. Given Jushi’s peers stronger consensus rating and higher probable upside, analysts clearly believe Jushi has less favorable growth aspects than its peers.
Profitability
This table compares Jushi and its peers’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Jushi | -24.16% | -320.66% | -10.31% |
Jushi Competitors | -45.95% | -62.18% | -9.03% |
Summary
Jushi peers beat Jushi on 9 of the 13 factors compared.
Jushi Company Profile
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabis dry flower, vaporizer forms of cannabis, edibles, cannabis oil in capsules, tinctures, cannabis in topical products, and other cannabis products, as well as vape cartridges, disposables, and concentrates under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. In addition, it operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. The company is headquartered in Boca Raton, Florida.
Receive News & Ratings for Jushi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jushi and related companies with MarketBeat.com's FREE daily email newsletter.